BWXT account plan
Nuclear innovation global security
At a glance
BWXT makes naval nuclear reactors, nuclear fuel and commercial nuclear components; 2025 revenues were $3,198.4 million with about 10,400 employees.
BWX Technologies, Inc. (BWXT) designs and manufactures naval nuclear components, reactors and nuclear fuel for the U.S. Government, manages government nuclear sites through joint ventures, and supplies components, fuel and services to commercial nuclear power, mainly in Canada. FY2025 revenues were $3,198.4 million (+18.3%), operating income $404.5 million and net income attributable to BWXT $328.9 million. The U.S. Government represented approximately 68% of 2025 revenues. It had about 10,400 employees at December 31, 2025, in the U.S., Canada and six other countries, and describes itself as having more than 11,000 employees in its Q3 2026 release. Rex D. Geveden is President and Chief Executive Officer.
Business units
Government Operations
about 73% of 2025 segment revenues ($2,350.1 million)Naval nuclear components, reactors and fuel for the Naval Nuclear Propulsion Program, uranium processing and downblending in Lynchburg and Erwin, management of U.S. and Canadian government nuclear sites through joint ventures, and advanced reactors for space and terrestrial use. Q3 2026 revenue was $639.1 million (+3.6%) with operating income of $122.6 million, 19.2% of revenues; backlog reached $6,482 million at September 30, 2026.
Commercial Operations
about 27% of 2025 segment revenues ($853.1 million)Steam generators, pressure vessels and reactor components (BWXT calls itself the only commercial heavy nuclear component manufacturer in North America), nuclear fuel and in-plant services for utilities, mainly in Canada, plus Kinectrics lifecycle services and medical isotopes. Q3 2026 revenue was $314.2 million (+25.2%) with an 8.4% operating margin; the medical business is being sold to Nordic Capital.
Strategic priorities
- 2030 growth targets
- At the 2026 Investor Day BWXT set a path to $5.5 billion to $6 billion of revenue and $1.1 billion to $1.2 billion of adjusted EBITDA by 2030, anchored to 5% to 6% core capex and requiring no M&A.
- Naval shipbuilding demand
- The Navy's updated 30-year plan calls for 2 Virginia-class and 1 Columbia-class submarine a year and moves Ford-class carriers to a 4-year cadence, with volume effects from about 2028; BWXT plans additional capex and hiring to meet it.
- Domestic enrichment and defense fuels
- BWXT is designing an HEU enrichment facility in Erwin, Tennessee, industrializing centrifuge technology at Oak Ridge, and building a depleted uranium (HPDU) facility in Jonesborough, Tennessee under a $1.6 billion contract.
- Commercial new-build orders
- Management expects new U.S. nuclear equipment orders possibly by year end and no later than about the first half of 2027, and is in final design of a new U.S. plant for large steam generators and reactor pressure vessels.
- Advanced reactors and TRISO fuel
- BANR was selected for the U.S. Army's Janus program and by Prodigy Clean Energy in Canada; Project PELE is to be delivered to Idaho National Laboratory, and the Lynchburg TRISO line can at least quadruple output.
Latest results
In Q3 2026 revenues were $953.0 million, up 10% from $866.3 million, GAAP operating income $132.1 million (+17%) and adjusted EBITDA $179.7 million (+19%); diluted EPS was $1.11 GAAP and $1.26 non-GAAP. Nine-month revenues reached $2,714.8 million (+17.4%). Free cash flow was $150.5 million in the quarter. Total backlog was $8,556.2 million at September 30, 2026. 2026 guidance: revenue about $3,800 million, adjusted EBITDA about $667 million, non-GAAP EPS $4.72-$4.77 and free cash flow $350-$360 million; the preliminary 2027 outlook is high-single-digit revenue growth.
Investments and deals
- Kinectrics acquisition
- Acquired May 20, 2025 for purchase consideration of CAD $614.5 million ($440.6 million), adding lifecycle management services; it brought $231.0 million of 2025 revenue.
- Precision Components Group acquisition
- Acquired July 1, 2026 for about $216.8 million to add U.S. commercial nuclear production capacity; it brought close to $500 million of backlog, 75% to 80% naval.
- Sale of the medical business
- Agreement signed July 31, 2026 to sell BWXT Medical and Kinectrics' stable isotope business to Nordic Capital at a valuation of up to $800 million, keeping a minority interest; closing expected in 2026 or Q1 2027.
- Capacity expansion capex
- Capex was $184.6 million in 2025 and $136.2 million in the first nine months of 2026, about 6% of revenue in 2026 and 2027; the Cambridge, Ontario expansion raises heavy component capacity by about 50%.
- Convertible notes refinancing
- In November 2025 BWXT issued $1.25 billion of 0% Convertible Senior Notes due 2030 and set up a new $1.25 billion revolving credit facility, undrawn at September 30, 2026.
Challenges and risks
- Reliance on government appropriations
- U.S. Government contracts depend on annual Congressional appropriations, continuing resolutions and shutdowns, and several significant contracts are periodically rebid.
- Timing of commercial new-build orders
- Management sees new-build final investment decisions held up by the distribution of risk among hyperscalers, utilities, government and vendors, and commercial demand depends on utility outage and refurbishment timing, mainly in Canada.
- Commercial margins
- Commercial Operations operating margin fell to 8.4% in Q3 2026 from 9.5% on product mix, acquisition and restructuring costs and SG&A investment.
- Skilled labour
- Skilled trades are harder to find than nuclear engineers, and the 10-K lists retention of qualified personnel and labor unions among its risks.
- Nuclear and environmental liabilities
- Environmental accruals were $107.2 million at the end of 2025, including the Shallow Land Disposal Area cleanup in Pennsylvania.
What leadership says
“our intense focus on operational excellence and cash generation”
“we've got multiple ways to win”
“fundamentally, what we're doing here is monetizing our IP”
“we can't shoot at everything that moves”
Where a supplier can help
- Plant construction and automation
- Tied to the Jonesborough HPDU facility, the Erwin enrichment design and the planned U.S. large-component plant: engineering, construction, automation and AI-enabled manufacturing suppliers have open projects.
- Skilled-trades recruiting and training
- Tied to the skilled labour challenge and hiring for naval shipbuilding demand: workforce sourcing, training and retention services fit the stated gap.
- Acquisition integration
- Tied to the Kinectrics and PCG acquisitions and rising restructuring and transformation costs: ERP, finance and integration services can help absorb the new businesses.
- Nuclear supply chain inputs
- Tied to the capacity expansion and TRISO fuel output: suppliers of forgings, precision components and specialty materials can support higher production volumes.
- Site services technology
- Tied to Technical Services at Hanford and Savannah River, which management says is adopting AI to improve site performance: digital and analytics tools for site operations fit.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like BWXT?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- BWX Technologies, Inc. Form 10-K for the fiscal year ended December 31, 2025
- BWX Technologies (NYSE: BWXT) is a specialty manufacturer of nuclear components, a developer of nuclear technologies and a service provider with more than 100 years of history; its core is precision naval nuclear components, reactors and fuel for the U.S. Government's Naval Nuclear Propulsion Program.
- FY2025 revenues rose 18.3% to $3,198.4 million (2024: $2,703.7 million); operating income was $404.5 million and net income attributable to BWXT $328.9 million, diluted EPS $3.58.
- Two segments: Government Operations (revenue $2,350.1 million, operating income $394.9 million, 16.8% margin) and Commercial Operations (revenue $853.1 million, up 62.8%, operating income $57.7 million, 6.8% margin).
- The U.S. Government represented approximately 68% of consolidated revenues in 2025 (76% in 2024); sales to large utilities were about 63% of Commercial Operations revenue.
- Backlog reached $7,261 million at December 31, 2025 (2024: $4,843 million), Government Operations $5,541 million and Commercial Operations $1,720 million; about 40% expected to be recognized by end of 2026, plus about $2,800 million of unexercised options excluded.
- Two acquisitions in 2025: Aerojet Ordnance Tennessee (A.O.T., from L3Harris, January 3, 2025, advanced special materials) and Kinectrics (May 20, 2025, CAD $782.7 million, lifecycle services for nuclear power and transmission/distribution plus medical isotopes, over 1,300 employees across 20 sites).
- Financing: $1.25 billion of 0% Convertible Senior Notes due 2030 issued in November 2025 and a new $1.25 billion revolving credit facility; liquidity of $1,748.4 million at year end; capex $184.6 million; dividends paid $92.5 million.
- About 10,400 employees (6,700 U.S., 3,500 Canada), approximately 3,200 unionized; key risks: dependence on U.S. Government appropriations, fixed-price contract cost overruns, nuclear operating, regulatory and environmental liabilities, single-source suppliers and acquisition integration.
- BWX Technologies, Inc. Form 10-Q for the quarter ended September 30, 2026
- Q3 2026 revenues rose 10.0% to $953.0 million (Q3 2025: $866.3 million); nine-month revenues rose 17.4% to $2,714.8 million.
- Q3 operating income $132.1 million (up $18.7 million); net income attributable to BWXT $101.7 million; diluted EPS $1.11 (Q3 2025: $0.89).
- Government Operations Q3 revenue $639.1 million (+3.6%), operating income $122.6 million (19.2% of revenues), driven by A.O.T. and enrichment operations.
- Commercial Operations Q3 revenue $314.2 million (+25.2%), operating income $26.3 million (8.4%); Precision Components Group added $26.2 million and on-site inspection, maintenance and refurbishment work $15.3 million.
- Backlog reached $8,556 million at September 30, 2026 (December 31, 2025: $7,261 million), with about 46% expected to be recognized by end of 2027.
- Portfolio moves: Precision Components Group acquired July 1, 2026 for about $216.8 million; definitive agreement on July 31, 2026 to sell the medical business (BWXT Medical and Kinectrics' stable medical isotope business) to Nordic Capital in a transaction valued at up to $800 million, now classified as held for sale.
- Nine-month operating cash flow $451.7 million; no borrowings under the $1.25 billion revolver; cash and investments $585.6 million.
- BWX Technologies Reports Third Quarter 2026 Results (earnings release, Exhibit 99.1)
- Q3 2026 revenues $953.0 million (+10%), net income $102.0 million, adjusted EBITDA $179.7 million (+19%), diluted GAAP EPS $1.11 and non-GAAP EPS $1.26 (+26%).
- Government Operations revenue $639.1 million (+4%) and adjusted EBITDA $144.2 million (+22%), driven by special materials and advanced nuclear, partly offset by lower naval propulsion volume.
- Commercial Operations revenue $314.2 million (+25%) and adjusted EBITDA $41.4 million (+17%), on commercial nuclear components, services and medical.
- BWXT Advanced Nuclear Reactor (BANR) selected for the U.S. Army's Janus Program at Fort Campbell and for Prodigy Clean Energy's Transportable Nuclear Power Plant project in Canada.
- 2026 guidance: revenue about $3,800 million, adjusted EBITDA about $667 million, non-GAAP EPS $4.72-$4.77, free cash flow $350-$360 million (2025: $3,198 million, $574 million, $4.01, $295 million).
- Preliminary 2027 outlook: high-single-digit revenue growth and high-single-digit to low-double-digit adjusted EBITDA and non-GAAP EPS growth.
- Q3 free cash flow $150.5 million (+59%); quarterly dividend $0.27 per share.
- BWX Technologies Q3 2026 earnings call transcript
- Geveden tied Q3 to the Investor Day path of $5.5 billion to $6 billion of revenue and $1.1 billion to $1.2 billion of adjusted EBITDA by 2030; Q3 delivered 10% revenue growth (7% organic) and 19% adjusted EBITDA growth.
- Government Operations adjusted EBITDA margin reached 22.6%; the annual fuel contract was booked for $189 million; defense fuels enrichment and high-purity depleted uranium (HPDU, a $1.6 billion contract for 300 metric tons a year) drove most of the segment's growth.
- Advanced nuclear: Project PELE core barrel assembly completed with delivery to Idaho National Laboratory next year; BANR selected for the Army's JANUS program (more than 20 microreactors across five bases) and by Prodigy in New Brunswick, the first international microreactor win; first large commercial TRISO fuel deal with Antares (1 metric ton).
- Commercial Operations organic revenue +15%, total +25%; the Cambridge, Ontario expansion raises heavy component capacity by about 50%; final investment decision on a new U.S. plant for large steam generators and reactor pressure vessels expected by year end, not dependent on firm orders.
- Geveden: "Commercial nuclear demand is precipitating rapidly on a global scale now"; he expects new U.S. reactor component orders by year end or no later than about the first half of 2027, with SMRs (Darlington units 2-4, TVA) ahead of large reactors.
- CFO Fitzgerald: 2027 Commercial Operations organic growth high single digits but low single-digit total growth after the medical divestiture, with margins up 50 to 100 basis points; capex about 6% of revenue in 2026 and 2027; Fitch investment-grade rating and Moody's positive outlook.
- On new-build delays Geveden points to "the distribution of risk" among hyperscalers, utilities, government and vendors rather than financing.
- BWXT Q2 2026 earnings call transcript
- Geveden said the nuclear industry is in the "early stages of a multi-decade super cycle of growth"; Q2 revenue rose 18% (9% organic), adjusted EBITDA 7% and adjusted EPS 5%; backlog $8.4 billion, up 40%, trailing book-to-bill 1.7x.
- Sale of just over 80% of BWXT Medical and Kinectrics' stable isotope business to Nordic Capital at up to $800 million ($750 million consideration plus shared economics), about $130 million of 2026 revenue; BWXT keeps a 20% stake. Geveden: medical was 3% of sales and "we can't shoot at everything that moves".
- Precision Components Group closed in early July, giving a U.S. commercial nuclear manufacturing platform; site selection for a large-component U.S. plant with deepwater port access among New Jersey, Indiana and one other option; $21 million DOE award.
- The Navy's 30-year plan (2 Virginia-class and 1 Columbia-class submarine a year, Ford-class carriers on 4-year centers) should remove the gap years in naval volume; a possible nuclear-powered battleship would use one Ford-class reactor.
- mPower SMR IP licensed exclusively to Applied Atomics for land use (BWXT keeps manufacturing rights, royalties and IP) and a feasibility study with Core Power for floating plants; Antares' Mark-0 reached criticality on BWXT TRISO fuel and HALEU.
- Guidance raised: revenue about $3.8 billion, adjusted EBITDA $662-$672 million, non-GAAP EPS $4.70-$4.80, free cash flow $345-$360 million; Government Operations margin about 20.5%, Commercial Operations about 13%.
Questions about BWXT
What does BWXT do?
BWXT designs and manufactures naval nuclear reactors, components and fuel for the U.S. Government, manages government nuclear sites, and supplies components, fuel and services to commercial nuclear power utilities, mainly in Canada.
What is BWXT's revenue?
FY2025 revenues were $3,198.4 million, up 18.3%. BWXT guides to about $3,800 million of revenue for 2026.
How many employees does BWXT have?
About 10,400 at December 31, 2025, of which 6,700 in the U.S. and 3,500 in Canada; the Q3 2026 release cites more than 11,000 employees.
What is BWXT's strategy to 2030?
BWXT targets $5.5 billion to $6 billion of revenue and $1.1 billion to $1.2 billion of adjusted EBITDA by 2030, driven by naval propulsion, defense fuels, commercial nuclear new builds and advanced reactors.
Who leads BWXT?
Rex D. Geveden is President and Chief Executive Officer, and Mike Fitzgerald is Senior Vice President and Chief Financial Officer.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)